CRMD CorMedix Inc
20,311
$5.12
$0.08
(1.54%)
| Watchers | 20,311 |
| 52-Wk Low | $2.57 |
| 52-Wk High | $7.00 |
| Market Cap | $281.39M |
| Volume | 475,555.00 |
| 52-Wk High | $7.00 |
| 52-Wk Low | $2.57 |
Commit To Buy CorMedix At $3, Earn 21.6% Annualized Using OptionsStock Options Channel • about 2 months ago
Investors considering a purchase of CorMedix Inc (CRMD) shares, but cautious about paying the going market price of 4.31/share, might benefit from considering selling puts among the alternative...
Share to Feed
BERKELEY HEIGHTS, N.J., March 27, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the...
This is a signal that CRMD's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...
CorMedix Inc. (NASDAQ:CRMD Get Free Report) CEO Joseph Todisco acquired 13,561 shares of the firms stock in a transaction that occurred on Wednesday, March 13th. The stock was...
This price move could be a signal that CRMD may fall back below the higher band and head toward the middle band. Traders may consider selling the stock, shorting the stock, or exploring put options...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
Net Loss Widens in Q4 and Full Year 2023; Company Prepares for Commercial LaunchRelated Stocks: CRMD...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...